Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001179110-19-006055

Director bought 4,650 shares at $21.44 ($99,696)

From the SEC's structured data for this filing

Trades in this filing

Coleman Mark · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-05-13 Purchase : show line 1 in the form +4,650 $21.44 $99,696 652,648 D
Open-market purchases · 4,650 sh · avg $21.44 · $99,696
Loading xslF345X03/edgar.xml…